Skip to main content

Table 4 The details of operative mortality in subgroups

From: Early and mid-term outcomes of open thoracoabdominal aortic aneurysm repair after thoracic endovascular aortic repair

Variable

n, %

Male gender (n = 43)

8 (12.7)

Prior smoke (n = 21)

3 (14.3)

Hypertension (n = 32)

7 (21.9)

Body mass index > 25 (n = 21)

3 (14.3)

Prior re-TEVAR (n = 26)

7 (26.9)

Prior frozen elephant trunk (n = 11)

3 (27.3)

Endoleak (n = 22)

6 (27.3)

 Type I endoleak (n = 18)

4 (22.2)

  I a (n = 6)

1 (16.7)

  I b (n = 6)

2 (33.3)

  I a + I b (n = 6)

1 (16.7)

 Type II endoleak (n = 4)

2 (50.0)

Mafan syndrome (n = 39)

5 (12.8)

Extent of TAAA

 I (n = 9)

1 (11.1)

 II (n = 22)

7 (31.8)

 III (n = 23)

2 (8.7)

 IV (n = 9)

1 (11.1)

Persisted false lumen perfusion (n = 36)

8 (22.2)

Pathology of aneurysms

 Degenerative (n = 3)

0 (0)

 Post-dissection (n = 60)

11 (18.3)

Emergency procedure (n = 10)

3 (30.0)

Aortic rupture (n = 9)

3 (33.3)

Simple aortic clamping (n = 8)

1 (12.5)

Aorto-iliac bypass (n = 20)

3 (15.0)

Femoro-femoral bypass (n = 35)

7 (20.0)

Deep hypothermic circulatory arrest (n = 22)

6 (27.3)

Cardiopulmonary bypass (n = 35)

7 (20.0)

Visceral branch reattachment (n = 50)

10 (20.0)

Reconstruction of the right iliac artery (n = 37)

5 (13.5)

Explantation of endograft (n = 31)

9 (29.0)

Without explantation of endograft (n = 32)

2 (6.3)

  1. Values are presented as number of deaths in this subgroup/total number in this subgroup (%)
  2. TAAA thoracoabdominal aortic aneurysm, TEVAR thoracic endovascular repair